Krka, d. d. (KRK.WA)
PLN 768.0
(6.08%)
PLN 768.0
(6.08%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.02 Billion EUR | 5.37% |
| 2022 | 974.39 Million EUR | 9.33% |
| 2021 | 891.2 Million EUR | -2.21% |
| 2020 | 911.32 Million EUR | 7.55% |
| 2019 | 847.36 Million EUR | 9.94% |
| 2018 | 770.72 Million EUR | 5.89% |
| 2017 | 727.85 Million EUR | 16.13% |
| 2016 | 626.75 Million EUR | -7.14% |
| 2015 | 674.95 Million EUR | -6.45% |
| 2014 | 721.46 Million EUR | 1.39% |
| 2013 | 711.56 Million EUR | 5.3% |
| 2012 | 675.74 Million EUR | 2.55% |
| 2011 | 658.92 Million EUR | 5.49% |
| 2010 | 624.61 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 286.93 Million EUR | 2.5% |
| 2024 Q1 | 279.94 Million EUR | 9.57% |
| 2023 Q3 | 227.48 Million EUR | -13.88% |
| 2023 Q4 | 255.49 Million EUR | 12.31% |
| 2023 FY | 1.02 Billion EUR | 5.37% |
| 2023 Q1 | 279.59 Million EUR | -4.66% |
| 2023 Q2 | 264.13 Million EUR | -5.53% |
| 2022 Q1 | 249.91 Million EUR | 10.34% |
| 2022 Q2 | 183.77 Million EUR | -26.47% |
| 2022 Q3 | 247.44 Million EUR | 34.65% |
| 2022 Q4 | 293.26 Million EUR | 18.52% |
| 2022 FY | 974.39 Million EUR | 9.33% |
| 2021 Q2 | 232.72 Million EUR | 2.06% |
| 2021 FY | 891.2 Million EUR | -2.21% |
| 2021 Q3 | 203.95 Million EUR | -12.36% |
| 2021 Q4 | 226.5 Million EUR | 11.06% |
| 2021 Q1 | 228.02 Million EUR | 8.7% |
| 2020 Q4 | 209.76 Million EUR | -4.05% |
| 2020 Q2 | 207.38 Million EUR | -24.74% |
| 2020 Q1 | 275.54 Million EUR | 19.18% |
| 2020 FY | 911.32 Million EUR | 7.55% |
| 2020 Q3 | 218.62 Million EUR | 5.42% |
| 2019 Q3 | 182.39 Million EUR | -16.42% |
| 2019 Q4 | 231.19 Million EUR | 26.75% |
| 2019 Q2 | 218.23 Million EUR | 1.26% |
| 2019 Q1 | 215.52 Million EUR | 1.26% |
| 2019 FY | 847.36 Million EUR | 9.94% |
| 2018 Q3 | 158.24 Million EUR | -22.66% |
| 2018 FY | 770.72 Million EUR | 5.89% |
| 2018 Q2 | 204.6 Million EUR | 4.91% |
| 2018 Q1 | 195.02 Million EUR | -1.56% |
| 2018 Q4 | 212.85 Million EUR | 34.51% |
| 2017 Q3 | 144.04 Million EUR | -31.3% |
| 2017 Q2 | 209.65 Million EUR | 19.09% |
| 2017 Q1 | 176.04 Million EUR | 5.38% |
| 2017 Q4 | 198.11 Million EUR | 37.54% |
| 2017 FY | 727.85 Million EUR | 16.13% |
| 2016 Q2 | 172.58 Million EUR | 1.42% |
| 2016 FY | 626.75 Million EUR | -7.14% |
| 2016 Q1 | 170.16 Million EUR | -4.81% |
| 2016 Q4 | 167.05 Million EUR | 42.85% |
| 2016 Q3 | 116.94 Million EUR | -32.24% |
| 2015 Q1 | 167.68 Million EUR | -19.03% |
| 2015 Q2 | 183.22 Million EUR | 9.27% |
| 2015 FY | 674.95 Million EUR | -6.45% |
| 2015 Q4 | 178.77 Million EUR | 23.05% |
| 2015 Q3 | 145.28 Million EUR | -20.71% |
| 2014 FY | 721.46 Million EUR | 1.39% |
| 2014 Q2 | 186.09 Million EUR | 4.58% |
| 2014 Q4 | 207.08 Million EUR | 37.73% |
| 2014 Q3 | 150.35 Million EUR | -19.2% |
| 2014 Q1 | 177.93 Million EUR | -7.28% |
| 2013 Q3 | 144.12 Million EUR | -27.06% |
| 2013 Q4 | 191.9 Million EUR | 33.15% |
| 2013 FY | 711.56 Million EUR | 5.3% |
| 2013 Q1 | 177.93 Million EUR | -6.54% |
| 2013 Q2 | 197.59 Million EUR | 11.05% |
| 2012 Q4 | 190.39 Million EUR | 35.93% |
| 2012 Q2 | 178.94 Million EUR | 7.57% |
| 2012 Q1 | 166.34 Million EUR | -7.63% |
| 2012 FY | 675.74 Million EUR | 2.55% |
| 2012 Q3 | 140.06 Million EUR | -21.72% |
| 2011 FY | 658.92 Million EUR | 5.49% |
| 2011 Q4 | 180.09 Million EUR | 0.0% |
| 2010 FY | 624.61 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Celon Pharma S.A. | 97.57 Million PLN | -952.225% |